Market Analysis and Insights: Global Viral Vaccine Media Market
Due to the COVID-19 pandemic, the global Viral Vaccine Media market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Serum-free Media accounting for % of the Viral Vaccine Media global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Research Institute segment is altered to an % CAGR throughout this forecast period.
China Viral Vaccine Media market size is valued at US$ million in 2021, while the US and Europe Viral Vaccine Media are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Viral Vaccine Media landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Viral Vaccine Media include Sartorius, Lonza, Thermo Fisher Scientific, Merck, Cytiva, HiMedia and PromoCell, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Viral Vaccine Media Scope and Segment
Viral Vaccine Media market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Viral Vaccine Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Serum-free Media
Stem Cell Media
Others
Segment by Application
Research Institute
Pharmaceutical
Others
By Company
Sartorius
Lonza
Thermo Fisher Scientific
Merck
Cytiva
HiMedia
PromoCell
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE